For the latest updates, visit or follow us on Twitter: @LillyDiabetes and About Eli Lilly and Company Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world
Editorial Advisory Board Member, Harvard Health Publishing Ozempic and other GLP-1 receptor agonists have gained attention for their role in treating type 2 diabetes and promoting weight loss
Explore BPC-157 Therapy TB-500 TB-500 is studied for pathways associated with cellular movement, tissue response and recovery
This pricing dynamic constrains overall market penetration and slows adoption despite the strong clinical benefits of GLP-1 therapies in weight management and glycemic control, making cost a key obstacle to broader global uptake
This mechanism helps explain why healing benefits often extend for weeks or months beyond the administration period
Protocol Overview Because Dihexa is dosed by mass rather than reconstituted to a concentration, a 10 mg capsule is simply that mass of solid dispersed in whatever organic vehicle a given protocol specifies there is no vial-and-water dilution to plan around